New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
07:29 EDTTGTX, HZNP, FPRX, DRNA, ZIOP, EBIO, RGDO, ESPR, KBIO, OMER, ATNMBioCentury to hold a conference
Future Leaders in the Biotech Industry Conference is being held in New York on March 28.
News For ATNM;RGDO;FPRX;OMER;EBIO;HZNP;KBIO;ZIOP;TGTX;ESPR;DRNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 20, 2015
13:21 EDTZIOPCAR T-Cell therapy drug stocks down sharply following NY Times story
Shares of biotechnology companies that are developing chimeric antigen receptor T cells or CAR T therapy drugs are falling sharply after a New York Times story titled "Riding High, Biotech Firms Remain Wary." WHAT'S NEW: Over the weekend, the New York Times published the story that struck a cautionary tone on the CAR-T therapy drugs. In this form of cancer treatment the patients own immune system cells are genetically manipulated to battle tumors. The New York Times story noted that there were some notable outcomes in the treatment of leukemia and lymphoma with the CAR T treatments but highlighted that the "technique is still early in development and can cause severe side effects." WHAT'S NOTABLE. Early last week, Intrexon (XON) and its oncology partner, ZIOPHARM Oncology (ZIOP), announced an exclusive licensing agreement with The University of Texas MD Anderson Cancer Center, including an exclusive sub-licensing agreement through MD Anderson for intellectual property developed at the University of Minnesota for the development of non-viral adoptive cellular cancer immunotherapies. Both companies' shares were up sharply following the announcement ZIOPHARM was up around 55% and Intrexon up over 30% the day following the announcement. PRICE ACTION: Shares of drug companies in the space are sharply lower in midday trading, with ZIOPHARM Oncology and Kite Pharma (KITE) each down over 9%, Intrexon down almost 12%, and Bellicum Pharmaceutical (BLCM) and bluebird bio (BLUE) each down almost 5%. Reference Link
07:06 EDTATNMActinium submits CMC meeting request to FDA for Iomab-B
Subscribe for More Information
05:54 EDTZIOPStocks with implied volatility movement; ZIOP INVN
Subscribe for More Information
January 16, 2015
17:11 EDTOMEROmeros files automatic mixed securities shelf
Subscribe for More Information
17:05 EDTOMEROmeros requests withdrawal of registration statement
Subscribe for More Information
10:14 EDTZIOPZiopharm mentioned cautiously by TheStreetSweeper blog
Subscribe for More Information
January 15, 2015
15:24 EDTFPRXAdage Capital Partners reports 6.09% passive stake in Five Prime
Subscribe for More Information
10:00 EDTHZNPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:14 EDTHZNPHorizon Pharma initiated with a Buy at UBS
Subscribe for More Information
January 14, 2015
16:33 EDTZIOPOn The Fly: Closing Wrap
Subscribe for More Information
12:49 EDTZIOPOn The Fly: Midday Wrap
Subscribe for More Information
10:10 EDTZIOPHigh option volume stocks
Subscribe for More Information
10:00 EDTZIOPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:16 EDTZIOPOn The Fly: Pre-market Movers
HIGHER: ZIOPHARM (ZIOP), up 53% after the company and Intrexon (XON) announced a licensing agreement with University of Texas. Intrexon shares are also up 12%... GameStop (GME), up 10.6% after reporting holiday SSS, providing guidance for the fourth quarter and fiscal 2014, and being upgraded at Pacific Crest... Smith Micro (SMSI), up 12.7% after reporting preliminary fourth quarter revenue and providing revenue guidance for the first quarter and fiscal 2015... BioCryst (BCRX), up 3.2% after receiving a positive opinion on EMA orphan drug designation for BCX4161... GoPro (GPRO), up 1% following analyst remarks that sell-off after yesterday's report on Apple (AAPL) patent was "overdone." DOWN AFTER EARNINGS: JPMorgan (JPM), down 2.7%... Wells Fargo (WFC), down 2.2%... Banking peers down as well, with Bank of America (BAC) down 2.8% and Citi (C) down 2%. ALSO LOWER: Tesla (TSLA), down 9% following comments made by CEO Elon Musk at an automotive conference in Detroit regarding a slowdown in China... New Media (NEWM), down 4.8% after 7M share spot secondary priced at $21.70... General Motors (GM), down 3% after giving 2015 guidance, saying it is on track to meet previously announced 2016 financial targets... Apple (AAPL), down 1% following lawsuit against Ericsson (ERIC) and countersuit filing.
08:55 EDTRGDORegado Biosciences to host conference call
Subscribe for More Information
08:43 EDTZIOPZiopharm upgraded at BMO Capital
As noted earlier, BMO Capital upgraded Ziopharm (ZIOP) to Outperform from Market Perform. The firm believes that the company's licensing deal with MD Anderson for CAR-T cancer treatments , announced yesterday, will be "transformational" for Ziopharm. The firm is upbeat on the outlook for CAR-T technology. Target to $15 from $1.
08:23 EDTZIOPZiopharm upgraded to Outperform from Market Perform at BMO Capital
08:07 EDTRGDORegado Biosciences and Tobira Therapeutics sign merger agreement
Subscribe for More Information
January 13, 2015
18:37 EDTZIOPOn The Fly: After Hours Movers
Subscribe for More Information
16:33 EDTZIOPIntrexon, Ziopharm announce licensing agreement with University of Texas
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use